Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia
A brief period of histotoxic hypoxia exhibits certain metabolic features resembling the in vivo situation of ischemia. In this study the neuroprotective effects of the peptidergic nootropic drug Cerebrolysin® (Cere) against iodoacetate induced histotoxic hypoxia were investigated. For that purpose isolated cortical neurons from 9 day chicken embryos were pre-cultured with 0 to 6.4mg.Cere/ml medium. At the 8th day in vitro histotoxic hypoxia was induced by incubation with 0.01 or 0.1mM iodoacetate. Cells were allowed to recover from toxic stress for 3, 6, 24 or 48 hours. Cere protected neurons dose dependently from delayed neuronal cell death due to 0.01 mM iodoacetate even after a recovery period of 48 h. After induction of histotoxic hypoxia by 0.1 mM iodoacetate high concentrations of Cere again led to neuronal protection after the 3 and 6 h recovery period. Moreover the influence of Cere on the cytoskeletal protein MAP2 in neurons submitted to 0.01 mM iodoacetate was investigated. With Western blotting and immuno-histochemical techniques it has been demonstrated that the drug clearly increased MAP2 abundance after histotoxic hypoxia. The present study points out that after severe damage of cortical neurons with iodoacetate Cere is able to protect neurons from delayed neuronal cell death maybe by maintaining neuronal plasticity due to avoidance of the cytoskeletal breakdown.
KeywordsCortical Neuron Neuronal Cell Death Cereb Blood Flow Toxic Stress MAP2 Abundance
Unable to display preview. Download preview PDF.
- Kitagawa K, Matsumoto M, Ninobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, Kamada T (1989) Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage — immunohistochemical investigation of dendritic damage. Neurosciences 31: 401–411CrossRefGoogle Scholar
- Koroleva VI, Korolev OS, Loseva E, Bures J (1998) The effect of MK-801 and of brain derived polypeptides on the development of focal brain ischemia induced by photothrombotic occlusion of the distal middle cerebral artery in rats. Brain Res (in press)Google Scholar
- Lindsay MR, Wiegand JST, Altar A, Distefano PS (1994) Neurotrophic factors: from molecule to man. TINS 17/5: 182–190Google Scholar
- Maiese K, Boniece I, Demeo D, Wagner AJ (1993) Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J Neurosci 13/7: 3034–3040Google Scholar
- Mattson MP, Cheng B (1993) Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 24: 136–140Google Scholar
- McCay PB, King MM (1980) Vitamin E: its role as a biologic free radical scavenger and its relationship to the microsomal mixed-function oxidase system. In: Machlin LJ (ed) Vitamin E. A comprehensive treatise. Marcel Dekker, New York, pp 289–317Google Scholar
- Olney JW (1993) Role of excitotoxins in developmental neuropathology. APMIS 40/101: 103–112Google Scholar
- Shoeman RL, Traub P (1990) Calpains and the cytoskeleton. In: Mellgren RL, Murachi T (eds) Intracellular calcium-dependent proteolysis. Raven Press, New York, pp 191–209Google Scholar
- White BC, Krause GS, O’Neil BJ, Degrada DJ, Tiffany BR, Grossman LI, Grunberger G (1993) Potential role of growth factors in global brain ischemia and reperfusion. The role of insulin-like growth factors in the nervous system. Brain Res 692: 281–283Google Scholar
- Windisch M, Piswanger A (1985) Beeinflussung des oxidativen Stoffwechsels von Hirn-, Leber-und Herzmuskelhomogenaten durch Peptidderivate und Kälberblutdialysat in vitro. Arzneimittelforschung/Drug Res 35: 87–89Google Scholar
- Windisch M, Paier B, Eggenreich U (1994) Neuronal growth factors and their role in degenerative brain diseases: a mini-review. Neurol Croat 43/2: 9–20Google Scholar